Skip to main content

Day: April 5, 2022

Bit Digital, Inc. and BitMine Immersion Technologies, Inc. Sign Letter of Intent for Hosting 7,000 ASIC Mining Computers

NEW YORK, April 05, 2022 (GLOBE NEWSWIRE) —  Bit Digital, Inc. (NASDAQ: BTBT) and BitMine Immersion Technologies, Inc. (OTC: BMNR) announce the signing of a Letter of Intent to establish a hosting relationship beginning with 7,000 current generation ASIC miners. The final agreement is expected to be completed in the coming weeks. The companies expect to primarily utilize the efficiencies of mining Bitcoin in immersion cooled containers, a process by which the servers run fully submerged in a dielectric fluid that efficiently cools the machines and allows for superior machine output and energy efficiency. The companies have agreed in principle to a mutually beneficial revenue split of the mined Bitcoin, and a multi-year term. Bryan Bullett, CEO of Bit Digital was quoted as saying “We are happy to begin our relationship with...

Continue reading

GGTOOR, Inc., (OTCMKTS:GTOR) Announces Management Report for the Week Ended April 2, 2022

Player Registration Has Grown by 1,733% in Two Years THOMASVILLE, GA, April 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – GGTOOR, Inc., (OTCMKTS:GTOR) (“GGTOOR, Inc.,”, “GTOR”, or the “Company”), an emerging leader in the eSports markets, announces it has been exactly two years since we started this journey, and it has been a remarkably busy two years for GGToor. The Company has seen amazing growth, with less than 3,000 player registrations at the end of 2020 to well over 55,000 player registrations tallied through the end of March 2022, that is an astonishing 1,733% increase! In addition, the Company has enjoyed 250,000 unique twitch viewers and over 450,000 twitter impressions. Another week of records being shattered! The Company completed tournaments in 4 or more different game titles for a record setting 7th week in a row!...

Continue reading

Agenus’ CD137 Agonist (AGEN2373) Advances in the Clinic, Triggering Milestone Payment from Gilead

LEXINGTON, Mass., April 05, 2022 (GLOBE NEWSWIRE) — Agenus Inc. (NASDAQ: AGEN), an immuno-oncology company with an extensive pipeline of therapeutics designed to activate immune response to cancers and infections, today announced receipt of a $5M clinical milestone payment for AGEN2373 (conditionally active CD137 agonist). AGEN2373 is being evaluated in a Phase 1b combination study with botensilimab (Fc-enhanced anti-CTLA-4), in melanoma patients who had relapsed on, or were refractory to, prior anti-PD-1 therapy. “The majority of patients treated with anti-PD-1 progress within a year and are in need of more effective treatment options,” said Steven O’Day, MD, Chief Medical Officer of Agenus. “Botensilimab has shown promising activity in a wide range of treatment-resistant cancers, including melanoma. The rationale to combine botensilimab...

Continue reading

American Metals Recovery and Recycling Rebrands to Multiband Global

New entity positioned to be a leading IT and network lifecycle company AUSTIN, TX, April 05, 2022 (GLOBE NEWSWIRE) — via NewMediaWire – American Metals Recovery and Recycling, Inc. (“AMRR”) (OTC Pink: AMRR) today announces its rebrand to Multiband Global, positioning itself as a leading IT and network lifecycle company offering solutions for the complete IT and network lifecycle. James Frinzi, Chairman and CEO, said, “The company has had a busy few months with our successful acquisition strategy, business development and advanced M&A activity in the pipeline. Our rebrand is an important operational milestone we’ve been looking forward to and marks the beginning of Multiband Global as a leading IT and network lifecycle company.” In February, Multiband Global announced it had completed an acquisition of AMR Resources, LLC and...

Continue reading

Rapid7 Announces the Creation of the Rapid7 Cybersecurity Foundation to Promote Access and Inclusion in Cybersecurity

Foundation will promote a diverse and inclusive workforce, advance free and open solutions for underserved and vulnerable communities, and conduct research and advocacy that strengthens cybersecurity outcomes and awareness for all BOSTON, April 05, 2022 (GLOBE NEWSWIRE) — Rapid7, Inc. (NASDAQ: RPD), a leading provider of security analytics and automation, today announced the formation of the Rapid7 Cybersecurity Foundation, a 501(c)(3) private foundation receiving all of its initial $1 million in funding from Rapid7. The Rapid7 Cybersecurity Foundation’s mission is to close the security achievement gap by making cybersecurity easier to access for the underrepresented and underserved. Its aim is to democratize cybersecurity by promoting a diverse and inclusive cyber workforce; supporting free and open security solutions; and advocating...

Continue reading

Processa Pharmaceuticals Announces First Patient Enrolled in the PCS12852 Phase 2A Trial for the Treatment of Gastroparesis

Study will advance understanding of proper dosing while providing data to assist in the design of the next study for this >$1B market Expect top line data at the end of 2022HANOVER, MD, April 05, 2022 (GLOBE NEWSWIRE) — Processa Pharmaceuticals, Inc. (NASDAQ: PCSA), (“Processa” or the “Company”), a clinical-stage biopharmaceutical company developing products to improve the survival and/or quality of life for patients who have an unmet medical need, announced today that it has enrolled its first patient in the Phase 2A clinical trial of PCS12852 in patients with moderate to severe gastroparesis. Gastroparesis is a chronic gastric motility disorder in which the stomach does not empty food as quickly as it should, resulting in potentially serious forms of heartburn, nausea, vomiting, and bloating for millions of patients in the...

Continue reading

Vaxcyte to Present at the 21st Annual Needham Virtual Healthcare Conference

SAN CARLOS, Calif., April 05, 2022 (GLOBE NEWSWIRE) — Vaxcyte, Inc. (Nasdaq: PCVX), a clinical-stage vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases, today announced that Company management will participate in a fireside chat at the 21st Annual Needham Virtual Healthcare Conference on Tuesday, April 12, 2022 at 12:45 p.m. ET. A live webcast of the presentation can be accessed through the Investors & Media section of the Company’s website at http://investors.vaxcyte.com. A replay of the webcast will be available for approximately 30 days following the conference. About VaxcyteVaxcyte is a vaccine innovation company engineering high-fidelity vaccines to protect humankind from the consequences of bacterial diseases. The Company is developing broad-spectrum...

Continue reading

Marathon Digital Holdings Announces Intent To Transition Hardin, Montana Bitcoin Mining Operations to More Sustainable Power Sources

Hardin Transition Reflects Marathon’s Commitment To Achieve 100% Carbon Neutrality by Year-End 2022 LAS VEGAS, April 05, 2022 (GLOBE NEWSWIRE) — Marathon Digital Holdings, Inc. (NASDAQ:MARA) (“Marathon” or “Company”), one of the largest enterprise Bitcoin self-mining companies in North America, today announced the Company’s intent to transition its bitcoin miners from the facility in Hardin, MT to new locations with more sustainable and non-carbon emitting sources of power. In 2021, Marathon announced that the Company’s mining operations would be 100% carbon neutral by year-end 2022. To achieve that goal and to build upon its current strategy, Marathon intends to transition its bitcoin miners from the facility in Montana, which currently derives its power from a coal-fired power plant, to new locations with...

Continue reading

Datasea Enters into a $7.88 Million Procurement Agreement to Provide 5G Messaging Smart City Solutions

BEIJING, April 05, 2022 (GLOBE NEWSWIRE) — Datasea Inc., (NASDAQ: DTSS) (“Datasea” or the “Company”), incorporated in Nevada in September 2014, is a digital technology corporation engaged in three converging and innovative business segments: 5G messaging, acoustic intelligence, and smart city technology in China. Today, the Company announced that Heilongjiang Xunrui Technology Co., Ltd. (“Xunrui”), a subsidiary of the Chinese operating company contractually controlled by the Company, has executed a purchase agreement with Jiangsu Xinrong Network Technology Research Institute Co., Ltd. (“Xinrong”), a company providing software development, artificial intelligence, and big data solutions. In conjunction with the agreement, Xinrong will establish and operate information systems for 100 residential...

Continue reading

Align Technology to Announce First Quarter 2022 Results on April 27, 2022

TEMPE, Ariz., April 05, 2022 (GLOBE NEWSWIRE) — Align Technology, Inc. (Nasdaq: ALGN) a leading global medical device company that designs, manufactures, and sells the Invisalign system of clear aligners, iTero intraoral scanners, and exocad CAD/CAM software for digital orthodontics and restorative dentistry, today announced that it will report first quarter 2022 financial results on Wednesday, April 27, 2022, after the close of market. Financial results will be released at 4:00 p.m. ET (1:00 p.m. PT) and will be available on the Investor Relations section of the Align website at http://investor.aligntech.com. Following the press release, Align will host a conference call to discuss its financial results. The conference call will begin at 4:30 p.m. ET (1:30 p.m. PT) and will also be available as an audio webcast live via the Internet....

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.